Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.88 and traded as high as $9.00. Hemispherx BioPharma shares last traded at $6.70, with a volume of 7,639 shares trading hands.
Hemispherx BioPharma Trading Down 20.0%
The company has a fifty day moving average price of $6.70 and a two-hundred day moving average price of $2.88.
Hemispherx BioPharma Company Profile
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Read More
- Five stocks we like better than Hemispherx BioPharma
- What Are Earnings Reports?
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- How to Use the MarketBeat Excel Dividend Calculator
- Congress: The Biggest Trades Impacting Markets Today
- Options Trading – Understanding Strike Price
- 3 Companies Boosting Buybacks While Others Pull Back
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
